The Seattle Cancer Care Alliance (SCCA) director of public relations is available to assist journalists with questions regarding SCCA, its partner organizations and its patients.

Our goal is to facilitate and encourage open and positive relationships between SCCA staff and the media while ensuring that all communications result in an accurate and appropriate portrayal of SCCA activities.

The public relations staff is committed to guarding the privacy and confidentiality of all patients undergoing treatment while recognizing the rights of the individual patient to discuss any and all aspects of his or her treatment and health status with the general public through the media. Patients must sign consent forms before any information will be given out.

Contact us

Journalists are welcome to visit SCCA. An escort will be available during visits. To arrange an interview, videotaping session or photo shoot, please contact:

Karina San Juan Guyton
SCCA Director of Communications & Public Relations
Media Coverage
Displaying 10 most recent
Sanofi’s, AstraZeneca’s and Radius’ oral SERDs could establish clinical worth in ER+ breast cancer by showing similar efficacy to Faslodex, experts say
Clinical Trials Arena · Published March 19, 2021
Evolving Landscape for Frontline Treatment in Clear Cell Metastatic Renal Cell Carcinoma
UroToday · Published March 18, 2021
New COVID-19 Treatment Advice and Vaccine Guidance for Cancer Patients
National Comprehensive Cancer Network · Published March 18, 2021
Helping spread kidney cancer awareness
Binaytara Foundation · Published March 17, 2021
‘On-your-toes’ approach to managing infection risk needed as CAR T-cell therapy evolves
Healio · Published March 17, 2021
Dr. Till on the Durability of Response With Brexucabtagene Autoleucel in MCL
OncLive · Published March 16, 2021
COVID-19 precautions shut down flu this season, but what will next winter bring?
The Seattle Times · Published March 14, 2021
Dr. Till on the Potential to Utilize CAR T-Cell Therapy Earlier in MCL
OncLive · Published March 4, 2021
Dr. Shadman on the Role of MRD in CLL
OncLive · Published March 3, 2021
Molecular Imaging Able to Determine Effectiveness of Treatment for AI-Refractory, ER+ Advanced Breast Cancer
Cancer Network · Published March 2, 2021
Press Releases
Displaying 10 most recent
Seattle Cancer Care Alliance Awards Community Health Grants to Regional Nonprofits
SCCA Staff · Published April 13, 2021
Seattle Cancer Care Alliance Selected as an Authorized Treatment Center for BreyanziTM/Liso-Cel CAR T-Cell Treatment
SCCA Staff · Published February 18, 2021
Seattle Cancer Care Alliance Celebrates 20 Years of Innovation in Cancer Treatment and Care
SCCA Staff · Published February 10, 2021
Seattle Cancer Care Alliance Among First Washington Healthcare Providers to Receive COVID-19 Vaccine
SCCA staff · Published December 15, 2020
SCCA to Present New Research at 62nd Annual Meeting of the ASH
Published December 4, 2020
Seattle Cancer Care Alliance Selected as an Authorized Treatment Center for Tecartus™, a Novel Immunotherapy Treatment
Published October 8, 2020
Seattle Cancer Care Alliance Nursing Staff Leads 10 Poster Presentations at Oncology Nursing Society Bridge Virtual Conference
Published September 8, 2020
Nearly 70 Seattle Cancer Care Alliance Providers Named to “Top Doctors” List
Published August 3, 2020
U.S. News & World Report Ranks Seattle Cancer Care Alliance Among the Top Ten Cancer Hospitals in the Nation for Over 10 years
Published July 28, 2020
An SCCA staff member participated in a local Seattle protest.
Published July 26, 2020